Dysregulated lncRNAs in CAD patients have functional interactions with Wnt/β-catenin, NF-κB, TGF-βR1/Smad, JAK/STAT, PTEN/AKT, and mTOR signaling pathways. The gene discussed is NFKB1; the disease is coronary artery disorder.